Physiologically-based pharmacokinetic modeling to support submission of brigimadlin (BI 907828) in dedifferentiated liposarcoma

Oncology

MIDD

Trial design and analysis

Regulatory interactions

Automation

PAGE 33 (2025) Abstr 11489

Kanacher T, Busse D, Sailer R, Sjögren E, Mezzalana E, Pellowe M, Chenel M, Gómez-Mantilla JD, Ince I.